Mesco Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 14, 2016, inter alia, to consider and take record the Un-audited Financial Results of the Company for the quarter and Half year ended September 30, 2016.
The above information is a part of company’s filings submitted to BSE.